Morphosis Capital finalizează vânzarea participației deținute în Medima către Simago, cu un multiplu al capitalului investit de 4,3x și un IRR de 31%

Morphosis Capital has successfully sold its stake in Medima to Simago, achieving a 4.3x capital multiple and a 31% IRR. This transaction marks a significant milestone for Medima, which has transformed from a single clinic in Bucharest to a national imaging network with 34 clinics across Romania. The deal was finalized after obtaining necessary approvals, with Simago acquiring a majority stake while Medima's co-founder Vlad Ardeleanu retains his shares and continues to lead the company. Morphosis Capital's investment in Medima began in 2020, and the company has since expanded significantly, enhancing access to high-quality diagnostic services. This exit is the third complete exit for Morphosis Capital Fund I, following previous successful transactions.

Fact-check this story: paste the text or link into Justificat.ro and get a verdict with the sources consulted.